Increased tumor necrosis factor alpha (TNF-α) and interleukin 1 alpha (IL1-α) levels in the lesional skin of patients with nonsegmental vitiligo [6]

International Journal of Dermatology

Volumn 45, Issue 8, 2006, Pages 992-993

  Birol, Ahu ^a,b   Kisa, Ucler ^a   Kurtipek, Gulcan Saylam ^a   Kara, Fatma ^a   Kocak, Mukadder ^a   Erkek, Emel ^a   Caglayan, Osman ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1ALPHA; LIQUID NITROGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; B LYMPHOCYTE ACTIVATION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LETTER; MALE; MELANOGENESIS; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PUNCH BIOPSY; RANK SUM TEST; SKIN BIOPSY; TISSUE LEVEL; VITILIGO;

ADULT; FEMALE; HUMANS; INTERLEUKIN-1ALPHA; MALE; SKIN; TUMOR NECROSIS FACTOR-ALPHA; VITILIGO;

EID: 33746583601     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02744.x     Document Type: Letter

References (12)

1. Ortonne JP. Vitiligo and other disorders of hypopigmentation. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Philadelphia: Elsevier, 2003: 947-950.
2. Gordon PR, Mansur CP, Gilchrest BA. Regulation of human melanocyte growth, dendricity, and melanization by keratinocyte-derived factors. J Invest Dermatol 1989; 92: 565-572.
3. Moretti S, Spallanzani A, Amato L, et al. New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 2002; 15: 87-92.
4. Santos-Rosa M, Bienvenu J, Whiher J. Cytokines. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. Philadelphia: Saunders, 1999: 549-552.
5. Piguet PF. Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin. Springer Semin Immunopathol 1992; 13: 345-354.
6. Reed JA, McNutt NS, Albino AP. Differential expression if basic fibroblast growth factor (b-FGF) in melanocytic lesions demonstrated by in-situ hybridization. Am J Pathol 1994; 144: 329-336.
7. Swope VB, Abdel-Malek Z, Kassem LM, et al. Interleukins 1α and 6 and tumor necrosis factor α are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 1991; 96: 180-185.
8. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
9. Santos-Rosa M, Bienvenu J, Whiher J. Cytokines. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. Philadelphia: Saunders, 1999: 587-592.
10. Martinez-Esparza M, Jimenez-Cervantes C, Solano F, et al. Mechanisms of melanogenesis inhibition by tumor necrosis factor-α in B16-F10 mouse melanoma cells. Eur J Biochem 1998; 255: 139-146.
11. Ozdemir M, Yillar G, Wolf R, et al. Increased basic fibroblast growth factor levels in serum and blister fluid from patients with vitiligo. Acta Derm Venereol 2000; 80: 438-439.
12. Horikawa T, Norris DA, Yohn JJ, et al. Melanocyte mitogens induce melanocyte chemikinesis and chemotaxis. J Invest Dermatol 1995; 104: 256-259.